Popescu M - Search Results

1

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.

Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G, Luo KX, Paik SW, Liaw YF, Button P, Popescu M. Fried MW, et al. Among authors: popescu m. Hepatology. 2008 Feb;47(2):428-34. doi: 10.1002/hep.22065. Hepatology. 2008. PMID: 18220290

2

Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.

Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J, Popescu M, Hadziyannis S; Peginterferon alfa-2a in HBeAg-negative Chronic Hepatitis B Study Group. Marcellin P, et al. Among authors: popescu m. Gastroenterology. 2009 Jun;136(7):2169-2179.e1-4. doi: 10.1053/j.gastro.2009.03.006. Epub 2009 Mar 19. Gastroenterology. 2009. PMID: 19303414 Clinical Trial.

3

Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Piratvisuth T, Lau G, Chao YC, Jin R, Chutaputti A, Zhang QB, Tanwandee T, Button P, Popescu M. Piratvisuth T, et al. Among authors: popescu m. Hepatol Int. 2008 Mar;2(1):102-10. doi: 10.1007/s12072-007-9022-5. Epub 2008 Feb 5. Hepatol Int. 2008. PMID: 19669285 Free PMC article.

4

Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients.

Piratvisuth T, Marcellin P, Popescu M, Kapprell HP, Rothe V, Lu ZM. Piratvisuth T, et al. Among authors: popescu m. Hepatol Int. 2013 Jun;7(2):429-36. doi: 10.1007/s12072-011-9280-0. Epub 2011 Jun 24. Hepatol Int. 2013. PMID: 21701902

5

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Brunetto MR, Farci P, Popescu M, McCloud P; Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Bonino F, et al. Among authors: popescu m. Gut. 2007 May;56(5):699-705. doi: 10.1136/gut.2005.089722. Epub 2006 Nov 24. Gut. 2007. PMID: 17127704 Free PMC article. Clinical Trial.

6

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients.

Marcellin P, Bonino F, Yurdaydin C, Hadziyannis S, Moucari R, Kapprell HP, Rothe V, Popescu M, Brunetto MR. Marcellin P, et al. Among authors: popescu m. Hepatol Int. 2013 Mar;7(1):88-97. doi: 10.1007/s12072-012-9343-x. Epub 2012 Mar 23. Hepatol Int. 2013. PMID: 23518903 Free PMC article.

7

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.

Sun J, Hou JL, Xie Q, Li XH, Zhang JM, Wang YM, Wang H, Lai JY, Chen SJ, Jia JD, Sheng JF, Chan HL, Wang JF, Li MK, Jiang M, Popescu M, Sung JJ. Sun J, et al. Among authors: popescu m. Aliment Pharmacol Ther. 2011 Aug;34(4):424-31. doi: 10.1111/j.1365-2036.2011.04750.x. Epub 2011 Jun 22. Aliment Pharmacol Ther. 2011. PMID: 21692822 Free article. Clinical Trial.

8

Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.

Reddy KR, Messinger D, Popescu M, Hadziyannis SJ. Reddy KR, et al. Among authors: popescu m. J Viral Hepat. 2009 Oct;16(10):724-31. doi: 10.1111/j.1365-2893.2009.01122.x. J Viral Hepat. 2009. PMID: 19486469 Clinical Trial.

9

Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir.

Yerly S, Rickenbach M, Popescu M, Taffe P, Craig C, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. Among authors: popescu m. Antivir Ther. 2001 Sep;6(3):185-9. Antivir Ther. 2001. PMID: 11808753

10

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.

Clotet B, Ruiz L, Martinez-Picado J, Negredo E, Hill A, Popescu M. Clotet B, et al. Among authors: popescu m. HIV Clin Trials. 2002 Jul-Aug;3(4):316-23. doi: 10.1310/67te-gpxq-r1lb-bpkg. HIV Clin Trials. 2002. PMID: 12187506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,086 results

Search Page

Filters